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Abstract 
Introduction: Intra-abdominal adhesions (IA) may occur after abdominal surgery and also may lead to complica-
tions such as infertility, intestinal obstruction and chronic pain. The aim of this study was to compare the effects of 
Mitomycin-C (MM-C) and sodium hyaluronate/carboxymethylcellulose [NH/CMC] on abdominal adhesions in a cecal 
abrasion model and to investigate the toxicity of MM-C on complete blood count (CBC) and bone marrow analyses.
Methods: The study comprised forty rats in four groups (Control, Sham, Cecal abrasion + MM-C, and Cecal abra-
sion + NH/CMC). On postoperative day 21, all rats except for the control (CBC + femur resection) group, were sacri-
ficed. Macroscopical and histopathological evaluations of abdominal adhesions were performed. In order to elucidate 
the side effects of MM-C; CBC analyses and femur resections were performed to examine bone marrow cellularity.
Results: CBC analyses and bone marrow cellularity assessment revealed no statistically significant differences 
between MM-C, NH/CMC and control groups. No significant differences in inflammation scores were observed 
between the groups. The MM-C group had significantly lower fibrosis scores compared to the NH/CMC and sham 
groups. Although the adhesion scores were lower in the MM-C group, the differences were not statistically significant.
Conclusion: Despite its potential for systemic toxicity, MM-C may show some anti-fibrosis and anti-adhesive effects. 
MM-C is a promising agent for the prevention of IAs, and as such, further trials are warranted to study efficacy.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Intraabdominal adhesions (IAs) are among the leading 
causes of postoperative complications (Celebioglu et  al. 
1999). IAs may occur due to surgical technique, trauma, 
foreign bodies (fibrin glue and oxidized-regenerated 
cellulose, patches, meshes, glove powder) and surgi-
cal sutures. Postoperative IAs have a significant impact 
on morbidity (chronic pain, infertility, partial or com-
plete small bowel occlusion, etc.) rates and also increase 
the workload in surgical units (Celebioglu et  al. 1999; 
Sulaiman et al. 2001; Brüggmann et al. 2010). It has been 
reported that up to 100  % of patients develop IA after 
surgical interventions (Sulaiman et al. 2001; Brüggmann 
et al. 2010). These patients frequently require a second-
ary adhesiolysis procedure and 8–32 % of these patients 
develop recurrent obstruction after the initial adhesioly-
sis procedure (Ellis 1997).
In view of the magnitude of the health problems 
and financial burden related to adhesions, prevention 
or reduction of postoperative adhesions has become 
an important priority (Holmdahl and Risberg 1997; 
Schnüriger et  al. 2011). Thus, prevention of IAs have 
been addressed by numerous experimental studies, 
although with limited success rates (Kamel 2010; Maciver 
et al. 2011).
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In an attempt to attain improved outcomes the use of 
good surgical technique and anti-adhesion adjuvants 
(Adept®, Interceed®, Seprafilm®, etc.) have been intro-
duced. Seprafilm® (sodium hyaluronate/carboxymethyl-
cellulose [NH/CMC], Genzyme Biosurgery Corporation, 
Cambridge, MA, USA) is the most widely studied adju-
vant for the prevention of adhesions (Gonzales-Quintero 
and Cruz-Pachano 2009). NH/CMC has been reported 
to be highly effective in reducing both the incidence and 
severity of polypropylene mesh related adhesions (Din-
smore et al. 2000). Moreover, the anti-adhesive affect of 
NH/CMC was not diminished by the presence of visceral 
trauma and the resultant inflammatory response (Kumar 
et al. 2009).
Mitomycin-C (MM-C) (Mitomycin-C® Kyowa Hakko 
Kogyo. Co. Ltd, Ohtemachi, Chiyoda-ku, Tokyo, Japan) 
is a promising agent that possess antiproliferative prop-
erties. It is an antineoplastic antibiotic that alkylates and 
crosslinks DNA (Kaufman et al. 2013). Local application 
of 0.02 % MM-C in topical eye solutions has been widely 
used in strabismus surgery to limit postoperative adhe-
sions in humans, in dacryocystorhinostomy to prevent 
the obstruction of common canaliculus (Cheng et  al. 
2013; Cano-Parra et  al. 1995; Mahindrakar et  al. 2001) 
and also to prevent pterygia recurrence after excision in 
rabbits (Minguini et al. 2000). Moreover, intraperitoneal 
administration of MM-C was found to be effective and 
safe for the prevention of primary or recurrent IAs in rats 
(Cubukçu et al. 2001).
In this experimental study, we aimed to substantiate 
the individual affects of NH/CMC and MM-C for reduc-
ing IAs in a rat cecal abrasion model. We hypothesized 
that the two agents would significantly reduce IAs. We 
also investigated the toxicity of MM-C by complete blood 
count (CBC) analysis and examination of rat bone mar-
row specimens in the groups that received MM-C and in 
the control group.
Methods
The experimental study was approved by the Animal 
Care and Use Ethics Committee of Gulhane Military 
Medical Academy. All animals received humane care 
in accordance with the Guide for the Care and Use of 
Laboratory Animals published by the National Institute 
of Health. Wistar albino female rats, weighing from 250 
to 300  g, were used in this experimental study. All rats 
were quarantined for 1 week prior to the onset of study. 
All surgical interventions were carried out under gen-
eral anesthesia using intramuscular 40  mg/kg ketamine 
hydrochloride (Ketalar®, Parke-Davis/Eczacıbası, Tur-
key) and 6  mg/kg Xylazine hydrochloride (Rompun®, 
Bayer, Mefar, Turkey). Sterile surgical technique was used 
throughout the study.
During the study design, authors assumed that the 
MM-C group would show inflammation and fibrosis 
scores of 3 and adhesion score of 4 in at least 10 % of rats. 
In comparison, sham group inflammation and fibrosis 
scores would be 3 and adhesion score would 4 in at least 
60  % of rats. Thus, the sample size for attaining an alfa 
error of 0.05 and a beta error of 0.20 would require at least 
10 rats per group. Accordingly, forty Wistar albino female 
rats were randomly and evenly assigned into four study 
groups. In order to elucidate the potential toxic effects of 
MM-C and decrease possible confounding factors, Group 
1 (control) was created and we analyzed the basal values 
CBC counts and bone marrow morphologies. Except for 
Group 1, all other study groups were given a laparotomy 
with a 3  cm midline incision. Afterwards, the cecum 
was exteriorized with approximately 1 cm2 of its antero-
medial serosal layer denuded by brushing ten times with a 
sterile toothbrush. Group 2 (sham) was administered 5 ml 
of saline solution intraperitoneally. Group 3 was adminis-
tered 1 mg/kg of MM-C in 5 ml of saline solution, intra-
peritoneally. In Group 4, a 1 × 1 cm NH/CMC sheet was 
directly applied on the abrasion area. The cecum was then 
returned to the abdominal cavity and the abdomen was 
closed with continuous 4/0 silk sutures.
On the 21st day, the rats were anesthesized and a sec-
ond laparotomy was performed through a U-shaped inci-
sion for optimum exposure. The adhesions were graded 
by a blinded surgeon using the criteria described by Nair 
et al. (1974) (Table 1; Fig. 1). Rats with adhesion grades 
of 0 and 1 were considered adhesion free or insubstan-
tial, grades between 2 and 4 were considered substantial 
or significant. Visceral and parietal tissues were resected 
and fixed in a 10 % formalin solution for at least 24 h by 
a blinded pathologist. Pathological examination of the 
specimens with adhesions were graded according to the 
presence of fibrosis and inflammation using a semiquan-
titative scoring system (Hooker et al. 1999) (Tables 2, 3).
Blood for CBC analysis was aspirated via caval punc-
ture during rat scarification. Then the femurs of rats (in 
MM-C and control groups) were amputated for bone mar-
row examination. Bones were decalcified using Shandon™ 
TBD-1™ Decalcifier (Thermo Scientific™, USA). These tis-
sues were embedded in paraffin blocks and cut into 6 μm 
sections. The sections were stained with haematoxylin–
eosin for bone marrow cellularity. Bone marrow cellularity 
assessment was performed by the blinded pathologist.
Statistical analysis was performed using SPSS Ver-
sion 15.0 (SPSS Inc., Chicago, IL, USA). Kruskal–Wallis 
test was used to compare continuous variables. Bonfer-
roni adjusted Mann–Whitney U and Dunnett’s multiple 
comparison test were used for comparing each group. 
Pearson Chi square test was used for comparisons of cat-
egorical variables. Statistical significance was set at 0.05.
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Results
None of the rats died as a result of anesthesia or in the 
follow-up period. There were no surgical wound related 
complications in any of the study groups. There were 
no statistically significant differences in white blood 
cell, neutrophil, red blood cell, hemoglobin, hematocrit, 
platelet counts between the control and other groups 
(p  >  0.05). The control and MM-C group bone marrow 
cellularities were similar and assessed histologically as 
normocellular (Fig. 1a, b).
Inflammation scores were distributed between 0 and 1 
in 70 % of the study groups and there were no statistically 
significant differences in inflammation scores between the 
study groups (p = 0.47). Analysis of fibrosis scores in the 
MMC group revealed that 100 % of scores were distributed 
between 0 and 1. Moreover, 70  % of Seprafilm and 80  % 
of sham group fibrosis scores were distributed between 2 
and 3, respectively. Statistical analysis showed that MMC 
group fibrosis scores were significantly lower than the 
Seprafilm and Sham group scores (p > 0.001). Interestingly, 
there was no statistically significant difference between the 
Seprafilm and Sham group fibrosis scores (p > 0.05).
The authors observed that the MM-C group had more 
insubstantial adhesions than the other groups. This was 
despite the fact that 70  % of the adhesion scores were 
scored as 0 and 1 in the MM-C group, 80 % as 1 and 2 
in the Seprafilm group, and 80 % as 2 and 3 in the NaCl 
group, however, the differences were not statistically sig-
nificant (p = 0.22) (Table 4; Fig. 2a, b). 
Table 1 Nair et al.’s grading criteria for adhesions in rats
Grade Description Classification
0 Complete absence of adhesions Insignificant adhesions insubstantial
1 Single band of adhesions between viscera or from one viscus to abdominal wall Insignificant adhesions insubstantial
2 Two bands, either between viscera or from viscera to abdominal wall Significant adhesions substantial
3 More than two bands between viscera or viscera to abdominal wall or whole of intestines forming 
a mass without being adherent to the abdominal wall
Significant adhesions substantial
4 Viscera directly adherent to abdominal wall regardless of number or extent of adhesive bands Significant adhesions substantial
Fig. 1 Bone marrow from control group (a) showing normal marrow cells (HEX40) Bone marrow from MMC group (b) resembles control group 
(HEX40)






Table 3 Inflammation grades
Score Microscopic changes
0 Null
1 Giant cells, occasional lymphocytes, and plasma cells
2 Giant cells, plasma cells, eosinophils, neutrophils
3 Many inflammatory cells, microabscesses
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Discussion
Adhesions gather tissues and organs that are not nor-
mally associated (Ahmad et  al. 2014). Incidence rates 
for abdominal adhesions have been estimated to be as 
high as 95  % after laparotomies (Attard and MacLean 
2007). The process of IAs may begin within a few hours 
after surgery, and most commonly (60–70 %) present as 
small bowel obstruction (SBO) (Catena et al. 2011). SBOs 
represent an important cause of hospital admissions 
that generate a substantial burden on healthcare sys-
tems worldwide and they are frequently associated with 
significant mortality and morbidity rates. Simple intesti-
nal obstructions and bowel necrosis/perforations related 
mortality rates have been reported as 3 and 30 %, respec-
tively (Catena et al. 2008). Additionally, numerous studies 
have also shown that pelvic adhesion is frequently associ-
ated with chronic pelvic pain and infertility (Rajab et al. 
2010; Howard 2000). The presence of IAs during repeated 
surgeries may increase the duration of surgery and also 
increase intraoperative complications, including damage 
to the intestines, bladder, ureters, and bleeding (Cheong 
et al. 2001). Even more drastically, 10- and 30-year SBO 
recurrence rates were 18 and 29 %, respectively, after an 
initial adhesiolysis procedure (Catena et al. 2008).
Collagen deposition in normal wound healing reaches 
a peak by the third week after the wound is created. After 
the third week, the wound undergoes constant altera-
tions, known as remodeling, which can last for years after 
the initial occurrence of the injury (Mercandetti et  al. 
1298). Thus, the current study was designed to sacrifice 
all rats on the 21st day in order to appropriately deter-
mine the extent of adhesions.
Although the exact pathological mechanisms that 
underly the formation of IAs have not been fully eluci-
dated; tissue injury, ischemia, infection and foreign bod-
ies are among the foremost factors that induce fibrin 
deposition (Zhou et al. 2007). Fibrin deposition is due to 
an imbalance between the fibrin-forming and fibrin-dis-
solving capacities of a peritoneum, which results in the 
formation of post-surgical adhesions (Ersoy et al. 2009). In 
order to establish effective treatment protocols that pre-
vent adhesion formation, a better understanding of the 
pathogenesis of IAs is required. Despite the fact that vari-
ous agents (interleukins, corticosteroids, nonsteroidal anti-
inflammatory drugs, lactated Ringer’s solution, dextran, 
Table 4 Distribution of  inflammation, fibrosis and  adhe-
sion scores between study groups









0 5 (50 %) 4 (40 %) 5 (50 %) 0.473
1 2 (20 %) 3 (30 %) 2 (20 %)
2 3 (30 %) 1 (10 %) 3 (30 %)
3 0 2 (20 %) 0
Fibrosis score
0 6 (60 %) 2 (20 %) 1 (10 %) 0.018a
1 4 (40 %) 1 (10 %) 1 (10 %)
2 0 2 (20 %) 2 (20 %)
3 0 5 (50 %) 6 (60 %)
Adhesion score
0 4 (40 %) 2 (20 %) 1 (10 %) 0.224
1 3 (30 %) 2 (20 %) 1 (10 %)
2 3 (30 %) 6 (60 %) 6 (60 %)
3 0 0 2 (20 %)
4 0 0 0
Fig. 2 Exemplary peritoneal adhesion after 21 days in the sham group from rat 4 (a) and rat 6 (b)
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etc.) to prevent postsurgical adhesion formation have been 
evaluated, none of these studied agents have proven suc-
cessful (Numanoğlu et al. 2007; Parsaei et al. 2013).
Theoretically, inert materials that form a barrier and 
prevent contact between the damaged serosal surfaces 
for the first few critical days may allow separate healing 
of injured surfaces and help in the prevention of adhesion 
formation (Schnüriger et al. 2011). One example of such 
material is Seprafilm, which is composed of hyaluronic 
acid with carboxymethylcellulose. It turns into a hydro-
philic gel 24 h after placement and provides a protective 
coat for traumatized tissues for up to 7 days (Kamel 2010).
MMC is another promising agent, and is an antibiotic 
isolated from a Streptomyces caespitosus broth. In addi-
tion to its antineoplastic effect, it also inhibits fibroblast 
proliferation (Attard and MacLean 2007). In this study, 
we evaluated the comparative effectiveness of MMC and 
HA/CMC for the prevention of IAs.
In a systematic review and meta-analysis, Zeng 
et  al. (2007) addressed the efficacy and safety of HA/
CMC. Their analysis concluded that HA/CMC could 
decrease abdominal adhesions after general surgery. 
However, they also reported that HA/CMC did not 
reduce postoperative intestinal obstructions and it 
increased abdominal abscess and anastomotic leak 
rates. In another study, Kumar et  al. searched several 
databases in order to determine the efficacy and safety 
of several agents that were used to prevent IAs. They 
reported that the use of a HA/CMC membrane reduced 
the incidence, extent and severity of adhesions in re-
operative abdominal surgery (Zeng et  al. 2007). Burns 
et al (1997) studied HA/CMC for the prevention of IAs 
in an experimental model under ischemic conditions. 
They concluded that HA/CMC was safe and effective 
in reducing postsurgical adhesions. In a recent study, 
Caglayan et  al. (2014) compared HA/CMC with ethyl 
pyruvate in rats. HA/CMC and ethyl pyruvate (EP) were 
found to reduce the formation IAs, however, no signifi-
cant difference was found between HA/CMC and EP. In 
comparison, Stawicki et  al. (2014) findings contrasted 
with other studies. The authors performed a prospective 
randomized controlled study. They reported that HA/
CMC showed no favorable effects on the elimination 
of adhesion formation. In the present study, there was 
no significant reduction in inflammation, fibrosis and 
adhesion scores in the HA/CMC group when compared 
to the sham group.
MM-C was investigated by Tander et al., Cubukcu et al., 
and Liu et  al. for the prevention of IAs in experimental 
models. All of these studies showed that MM-C effectively 
prevented the formation of adhesions (Ahmad et al. 2014; 
Tander et  al. 2007; Liu et  al. 2005). As mentioned above, 
the efficacy of MM-C has been well established in various 
clinical settings (Kaufman et  al. 2013; Cheng et  al. 2013; 
Cano-Parra et al. 1995; Mahindrakar et al. 2001; Minguini 
et  al. 2000; Numthavaj et  al. 2013; Daher et  al. 2007; Lee 
et  al. 2011; Nagaich et  al. 2014). MM-C has become the 
agent of choice with favorable results in reducing postopera-
tive scar formation. In the present study, MM-C showed no 
significant affect on inflammation scores. However, MM-C 
significantly reduced fibrosis scores and also showed a ten-
dency towards the reduction of adhesion scores.
Phılıps et  al. (1960) studied MM-C related toxic side 
effects in rats and mice. They reported that weight loss, 
bloody masks, diarrhea, etc., were evident within 4 days 
of application. In sternal bone marrow, cellularities 
were reduced in quantity and the reduction rates were 
10–50  % at 9  days. They also described a lethal dose 
(LD50) of 2.5 mg/kg for MM-C, after a single or multiple 
intraperitoneal injections for 5 days. A limitation of the 
current study includes the fact that scarification was per-
formed after 21  days of follow up. Thus, MM-C related 
transient complications in the hematopoietic system or 
on bone marrow cellularity may have been overlooked. 
However, the authors of the study have not observed or 
demonstrated any MMC related toxic or lethal effects. 
Another limitation of the study stems from the fact that 
the anti-adhesive affects of MM-C were not compared 
in different application doses. Thus, we were unable to 
assess the relationship between dose dependent anti-
adhesive affects and toxic complications of MM-C.
Conclusion
Despite its potential for systemic toxicity, Mitomycin-
C shows some anti-fibrosis and anti-adhesive effects. 
MM-C is a promising agent for the prevention of IAs, 
and as such, further trials are warranted to study efficacy.
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